The North America Prosthetic Heart Valve Market would witness market growth of 10.1% CAGR during the forecast period (2022-2028).
A prosthetic heart valve, also called an artificial heart valve, is a one-way valve that is placed into a patient's heart to replace a malfunctioning heart valve. Mechanical heart valves, bioprosthetic tissue valves, and designed tissue valves are the three types of artificial heart valves. Prosthetic heart valves are rapidly being used to replace native heart valves that need to be replaced. The purpose of an artificially implanted valve is for it to function like a natural valve in terms of hemodynamics and side effects (low thrombogenicity). Bioprosthetic valves have similar functional features to native valves (e.g., hemodynamics, thrombosis resistance), but their lifetime is limited compared to mechanical valves.
The tricuspid, pulmonary, mitral, and aortic valves are four valves that open and close when blood flows through the heart. The right atrium is where blood enters the heart and travels to the right ventricle via the tricuspid valve. Blood is then directed into the lungs via the pulmonary valve. After being oxygenated, blood travels to the left atrium, where it is pumped to the left ventricle via the mitral valve. The aortic valve transports blood from the left ventricle to the aorta. Birth defects, age-related changes, and impacts from other conditions, such as rheumatic fever and infections that cause endocarditis, are all possible causes of heart valve deterioration.
There is a significant prevalence of valvular heart diseases in the United States. According to the Center for Disease Control and Prevention, valvular heart disease affects about 2.5% of the population in the United States. Valvular heart disease affects about 13% of people born before 1943. The mitral valve (which has only two leaflets and the aortic valve are the most usually impacted by rheumatic heart disease, although any valve can be impacted, and more than one can be involved. Bicuspid aortic valves (those with only two leaflets instead of the usual three) affect approximately 1% to 2% of the population and are more common in men. In the United States, there were 3,046 deaths from rheumatic valvular heart disease in 2017 and 24,811 deaths from non-rheumatic valvular heart disease.
Moreover, Mitral Valve Disease is one of the most prevalent heart valve diseases in the United States, which compels a significant number of people to go under a heart valve transplant surgery. Therefore, due to the surging prevalence of valvular diseases in the region, the demand for prosthetic heart valves is estimated to increase. This factor is bolstering the growth of the regional prosthetic heart valve market.
The US market dominated the North America Prosthetic Heart Valve Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $3,508.5 million by 2028. The Canada market is estimated to grow at a CAGR of 12.6% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 11.6% during (2022 - 2028).
Based on End User, the market is segmented into Hospitals & Cardiac Centers and Ambulatory Surgical Centers & Others. Based on Product, the market is segmented into Transcatheter, Tissue, and Mechanical. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Prosthetic Heart Valve Market is Estimated to reach $13.3 Billion by 2028, at a CAGR of 10.7%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Medtronic PLC, Abbott Laboratories, Meril Life Science Private Limited, Colibri Heart Valve LLC, Artivion, Inc., TTK Healthcare Limited, Edwards Lifesciences Corporation, JenaValve Technology, Inc., and Micro Interventional Devices, Inc.
Scope of the Study
Market Segments Covered in the Report:
By End User
- Hospitals & Cardiac Centers
- Ambulatory Surgical Centers & Others
By Product
- Transcatheter
- Tissue
- Mechanical
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Boston Scientific Corporation
- Medtronic PLC
- Abbott Laboratories
- Meril Life Science Private Limited
- Colibri Heart Valve LLC
- Artivion, Inc.
- TTK Healthcare Limited
- Edwards Lifesciences Corporation
- JenaValve Technology, Inc.
- Micro Interventional Devices, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Prosthetic Heart Valve Market, by End User
1.4.2 North America Prosthetic Heart Valve Market, by Product
1.4.3 North America Prosthetic Heart Valve Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Approvals and Trials
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Acquisitions and Mergers: 2019, Mar – 2021, Oct) Leading Players
Chapter 4. North America Prosthetic Heart Valve Market by End User
4.1 North America Hospitals & Cardiac Centers Market by Country
4.2 North America Ambulatory Surgical Centers & Others Market by Country
Chapter 5. North America Prosthetic Heart Valve Market by Product
5.1 North America Transcatheter Market by Country
5.2 North America Tissue Market by Country
5.3 North America Mechanical Market by Country
Chapter 6. North America Prosthetic Heart Valve Market by Country
6.1 US Prosthetic Heart Valve Market
6.1.1 US Prosthetic Heart Valve Market by End User
6.1.2 US Prosthetic Heart Valve Market by Product
6.2 Canada Prosthetic Heart Valve Market
6.2.1 Canada Prosthetic Heart Valve Market by End User
6.2.2 Canada Prosthetic Heart Valve Market by Product
6.3 Mexico Prosthetic Heart Valve Market
6.3.1 Mexico Prosthetic Heart Valve Market by End User
6.3.2 Mexico Prosthetic Heart Valve Market by Product
6.4 Rest of North America Prosthetic Heart Valve Market
6.4.1 Rest of North America Prosthetic Heart Valve Market by End User
6.4.2 Rest of North America Prosthetic Heart Valve Market by Product
Chapter 7. Company Profiles
7.1 Boston Scientific Corporation
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Product Launches and Product Expansions:
7.1.5.2 Acquisition and Mergers:
7.1.6 SWOT Analysis
7.2 Medtronic PLC
7.2.1 Company overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Approvals and Trials:
7.2.6 SWOT Analysis
7.3 Abbott Laboratories
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Product Launches and Product Expansions:
7.3.5.2 Acquisition and Mergers:
7.3.5.3 Approvals and Trials:
7.3.6 SWOT Analysis
7.4 Meril Life Sciences Private Limited
7.4.1 Company Overview
7.4.2 Recent strategies and developments:
7.4.2.1 Product Launches and Product Expansions:
7.5 Colibri Heart Valve LLC
7.5.1 Company Overview
7.6 Artivion, Inc. (CryoLife, Inc.)
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 Recent strategies and developments:
7.6.5.1 Acquisition and Mergers:
7.7 TTK Healthcare Limited
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.8 Edwards Lifesciences Corporation
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expenses
7.8.5 Recent strategies and developments:
7.8.5.1 Acquisition and Mergers:
7.8.5.2 Approvals and Trials:
7.9 JenaValve Technology, Inc.
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Geographical Expansions:
7.10. Micro Interventional Devices, Inc.
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Approvals and Trials:
TABLE 1 North America Prosthetic Heart Valve Market, 2018 - 2021, USD Million
TABLE 2 North America Prosthetic Heart Valve Market, 2022 - 2028, USD Million
TABLE 3 Approvals and Trials – Prosthetic Heart Valve Market
TABLE 4 Product Launches And Product Expansions – Prosthetic Heart Valve Market
TABLE 5 Acquisition and Mergers – Prosthetic Heart Valve Market
TABLE 6 North America Prosthetic Heart Valve Market by End User, 2018 - 2021, USD Million
TABLE 7 North America Prosthetic Heart Valve Market by End User, 2022 - 2028, USD Million
TABLE 8 North America Hospitals & Cardiac Centers Market by Country, 2018 - 2021, USD Million
TABLE 9 North America Hospitals & Cardiac Centers Market by Country, 2022 - 2028, USD Million
TABLE 10 North America Ambulatory Surgical Centers & Others Market by Country, 2018 - 2021, USD Million
TABLE 11 North America Ambulatory Surgical Centers & Others Market by Country, 2022 - 2028, USD Million
TABLE 12 North America Prosthetic Heart Valve Market by Product, 2018 - 2021, USD Million
TABLE 13 North America Prosthetic Heart Valve Market by Product, 2022 - 2028, USD Million
TABLE 14 North America Transcatheter Market by Country, 2018 - 2021, USD Million
TABLE 15 North America Transcatheter Market by Country, 2022 - 2028, USD Million
TABLE 16 North America Tissue Market by Country, 2018 - 2021, USD Million
TABLE 17 North America Tissue Market by Country, 2022 - 2028, USD Million
TABLE 18 North America Mechanical Market by Country, 2018 - 2021, USD Million
TABLE 19 North America Mechanical Market by Country, 2022 - 2028, USD Million
TABLE 20 North America Prosthetic Heart Valve Market by Country, 2018 - 2021, USD Million
TABLE 21 North America Prosthetic Heart Valve Market by Country, 2022 - 2028, USD Million
TABLE 22 US Prosthetic Heart Valve Market, 2018 - 2021, USD Million
TABLE 23 US Prosthetic Heart Valve Market, 2022 - 2028, USD Million
TABLE 24 US Prosthetic Heart Valve Market by End User, 2018 - 2021, USD Million
TABLE 25 US Prosthetic Heart Valve Market by End User, 2022 - 2028, USD Million
TABLE 26 US Prosthetic Heart Valve Market by Product, 2018 - 2021, USD Million
TABLE 27 US Prosthetic Heart Valve Market by Product, 2022 - 2028, USD Million
TABLE 28 Canada Prosthetic Heart Valve Market, 2018 - 2021, USD Million
TABLE 29 Canada Prosthetic Heart Valve Market, 2022 - 2028, USD Million
TABLE 30 Canada Prosthetic Heart Valve Market by End User, 2018 - 2021, USD Million
TABLE 31 Canada Prosthetic Heart Valve Market by End User, 2022 - 2028, USD Million
TABLE 32 Canada Prosthetic Heart Valve Market by Product, 2018 - 2021, USD Million
TABLE 33 Canada Prosthetic Heart Valve Market by Product, 2022 - 2028, USD Million
TABLE 34 Mexico Prosthetic Heart Valve Market, 2018 - 2021, USD Million
TABLE 35 Mexico Prosthetic Heart Valve Market, 2022 - 2028, USD Million
TABLE 36 Mexico Prosthetic Heart Valve Market by End User, 2018 - 2021, USD Million
TABLE 37 Mexico Prosthetic Heart Valve Market by End User, 2022 - 2028, USD Million
TABLE 38 Mexico Prosthetic Heart Valve Market by Product, 2018 - 2021, USD Million
TABLE 39 Mexico Prosthetic Heart Valve Market by Product, 2022 - 2028, USD Million
TABLE 40 Rest of North America Prosthetic Heart Valve Market, 2018 - 2021, USD Million
TABLE 41 Rest of North America Prosthetic Heart Valve Market, 2022 - 2028, USD Million
TABLE 42 Rest of North America Prosthetic Heart Valve Market by End User, 2018 - 2021, USD Million
TABLE 43 Rest of North America Prosthetic Heart Valve Market by End User, 2022 - 2028, USD Million
TABLE 44 Rest of North America Prosthetic Heart Valve Market by Product, 2018 - 2021, USD Million
TABLE 45 Rest of North America Prosthetic Heart Valve Market by Product, 2022 - 2028, USD Million
TABLE 46 key Information – Boston Scientific Corporation
TABLE 47 Key Information – Medtronic PLC
TABLE 48 Key Information – Abbott Laboratories
TABLE 49 Key Information – Meril Life Sciences Private Limited
TABLE 50 Key Information – Colibri Heart Valve LLC
TABLE 51 Key Information – Artivion, Inc.
TABLE 52 Key Information – TTK Healthcare Limited
TABLE 53 Key Information – Edwards Lifesciences Corporation
TABLE 54 Key Information – JenaValve Technology, Inc.
TABLE 55 Key Information – Micro Interventional Devices, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Acquisitions and Mergers: 2019, Mar – 2021, Oct) Leading Players
FIG 5 Recent strategies and developments: Boston Scientific Corporation
FIG 6 SWOT Analysis: Boston Scientific Corporation
FIG 7 Swot analysis: Medtronic plc
FIG 8 Recent strategies and developments: Abbott Laboratories
FIG 9 Swot analysis: Abbott laboratories